BlackBoxRX
 
We highly recommend enabling Javascript while using the BlackBoxRX site.

Trovafloxacin

Hepatotoxicity

  • Severe leading to transplantation and death. Risk increased with > 2 weeks duration. Use only in life-threatening infections and in an inpatient facility. Should not be used when safer alternatives are available.

MONITORING RECOMMENDATIONS RELATED TO BLACK BOX DATA

  • Monitor LFTs in patients who develop signs/symptoms consistent with hepatitis. Consider discontinuing drug in patients who develop elevated LFTs.

Patient Counseling Information

Package Inserts

Trovafloxacin

Additional Information

Updated January 2018